Skip to content
FY'25FY'24FY'23FY'22
Returns
Return on equity-10.9%+21.7pp-32.7%-9.4pp-23.3%-5.3pp-18%+1.9pp
Return on assets-10.2%+20.8pp-31%-9.2pp-21.8%-6.5pp-15.2%-0.6pp
Return on invested capital-16.5%+28.3pp-44.8%-9.0pp-35.8%-10.7pp-25.1%+3.9pp
Liquidity
Current ratio11.3×-3.6×15×-4.7×19.7×+8.0×11.7×+6.1×
Quick ratio11.3×-3.6×15×-4.7×19.7×+8.0×11.7×+6.1×
Cash ratio1.9×+0.1×1.8×-4.0×5.8×+3.6×2.2×+0.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Per Share
Book value per share$11.56-10.8%$12.97+20.1%$10.80+28.1%$8.43-1.4%
Valuation
Market capitalization$3.03B+36.4%$2.22B-4.3%$2.32B+166%$874.22M-3.9%
Enterprise value$2.95B+36.6%$2.16B-0.5%$2.17B+168%$809.07M-1.7%
Price / book+0.9×2.1×-1.6×3.7×+1.2×2.5×-0.5×
Free cash flow yield-2.4%+8.9pp-11.3%-6.3pp-5.1%+5.3pp-10.4%-3.9pp
Earnings yield-3.8%+8.6pp-12.4%-7.5pp-4.9%+1.8pp-6.7%-1.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do IDEAYA Biosciences, Inc.'s ratios come from?
Every ratio is computed from IDEAYA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.